AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Antiplatelet and anticoagulant drugs are classified antithrombotic agents with the purpose to reduce blood clot formation. For a successful treatment of many known complex cardiovascular diseases driven by platelet and/or coagulation activity, the need of more than one antithrombotic agent is inevitable. However, combining drugs with different mech...
Alternative Titles
Full title
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8724117
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8724117
Other Identifiers
ISSN
1618-2642,1618-2650
E-ISSN
1618-2650
DOI
10.1007/s00216-021-03765-y
